http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2120049-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c58a89c3439adb624ee177b38988f98 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7452 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2008-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d6de9bfabda82bd98b660437588775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd01b303f6ec23790adb51b3ed81ba0f |
publicationDate | 2009-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2120049-A1 |
titleOfInvention | Soluble thrombomodulin as a biomarker for treatments using anticoagulants |
abstract | An in vitro method of selecting a patient suitable for anticoagulant therapy comprising the steps of: e. Taking a sample of a body fluid, cells or tissue from the patient, f. Determination of the soluble thrombomodulin in the sample taken, G. Comparison of the determined concentration or activity of the soluble thrombomodulin in the sample with a standard value, H. Selecting the patient whose sample does not have a significantly increased concentration or activity of soluble thrombomodulin compared to the standard for anticoagulant treatment. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012160031-A1 |
priorityDate | 2008-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 358.